ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 729166 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 729166; 2) Community: the network communities that were significantly associated with the response to NSC 729166; 3) Molecule: the relationships between components within communities and NSC 729166; 4) MDR: the compounds that were significantly associated with the NSC 729166.

NSC Compound Enrichment Correlation
NSC 637128 Null 0.00838963112864943 -0.024369173
NSC 643860 Null 0.00838963112864943 -0.10108063
NSC 648265 [3-keto-Bmt(sup 1)]-[Val(sup 2)]-Cyclosporin 0.00838963112864943 -0.030776833
NSC 681637 Camptothecin Derivative 0.00838963112864943 -0.10581664
NSC 690633 Null 0.00838963112864943 0.11102669
NSC 702015 1H-Indole-2-carboxylic acid, 2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl ester, (11aS)- 0.00838963112864943 -0.27093225
NSC 702759 Null 0.00838963112864943 -0.049615419
NSC 744020 methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate 0.00841144976667928 0.089727291
NSC 350895 Bleomycin A5 0.00841144976667934 -0.17210882
NSC 627744 Null 0.00841144976667934 -0.12290251
Total:65  Current:12    [First] [Prev] [Next] [Last]